The 1 Billion Dose Wager on the IP Waiver 21/05/2021 Elaine Ruth Fletcher & Svĕt Lustig Vijay Rich countries need to cough up 1 billion vaccine doses by September, and big pharma should significantly expand its network of voluntary license sharing and manufacturing – in order to avoid a vote by World Trade Organization members on a controversial proposal to waive all COVID-related intellectual property for the duration of the pandemic. That […] Continue reading -> Sustainable COVAX Vaccine Funding & Voluntary Manufacturing Licenses are Better Solutions than IP Waiver, Says IFPMA Head 16/05/2021 Elaine Ruth Fletcher In preparation for the next pandemic, the COVAX global vaccine facility “needs a pot of money, where they can be early movers” in competing for, and securing, vaccine doses. That could help scenarios like the ones seen recently, in which rich countries cornered the market on the first available COVID-19 vaccines, leading to severe shortages […] Continue reading -> WTO’s DG Okonjo-Iweala Welcomes New US Support For Waiver On COVID Vaccine IP: ‘We Need To Respond Urgently’ 06/05/2021 Chandre Prince, Raisa Santos & Elaine Ruth Fletcher World Trade Organization’s (WTO) director general Ngozi Onkonjo-Iweala on Thursday hailed the United States government’s decision to support the suspension of intellectual property rules on COVID-19 vaccines – while also emphasising the urgency of even more immediate actions to increase vaccine supplies to lower-income countries. In a statement after a two-day closed-door WTO General […] Continue reading -> BREAKING – US Swings Weight Behind Global IP Waiver On COVID Vaccines; WTO Inches Towards ‘Text-Based’ Negotiations 05/05/2021 Elaine Ruth Fletcher The United States has swung its weight behind a hotly-debated proposal by India and South Africa to suspend intellectual property rights on COVID-19 vaccines for the duration of the pandemic. The dramatic turnabout in the US position, announced Wednesday evening by US Trade Representative Katherine Tai, signals a sea change in the balance of powers […] Continue reading -> WHO Inches Closer to Approval of Chinese Sinopharm and Sinovac Vaccines 03/05/2021 Svĕt Lustig Vijay The World Health Organization (WHO) appears to be inching towards the approval of the Chinese Sinopharm and Sinovac vaccines as it struggles to fill a looming vaccine vacuum left by India’s Serum Institute – which has halted exports as the country continues to reel from a tragic coronavirus outbreak. Meanwhile, the WHO declared the latest […] Continue reading -> New Wave Of Appeals For WTO Waiver On IP For COVID Treatments Ahead of TRIPS Council Meeting 27/04/2021 Elaine Ruth Fletcher Nearly 400 members of the European Parliament (MEPs) and of national parliaments from across the European Union issued a joint appeal Tuesday calling for the European Commission to drop its opposition to a proposed WTO waiver on IP related to COVID-19 health technologies for the duration of the pandemic, being co-sponsored by India and South […] Continue reading -> The ‘Patent Bargain’, Public Good & COVID19 26/04/2021 Priti Patniak/Geneva Health Files As the hotly contested proposal for an IP waiver on COVID-related health products comes up again for debate on Friday, 30 April at the World Trade Organization’s TRIPS Council, legal expert Hyo Yoon Kang looks at the foundations of IP law to challenge “TRIPS waiver” naysayers. Geneva Health Files [GHF]: You have argued that IP […] Continue reading -> Gavi Receives $400 Million in Donations at High-Level Event To Expand Global Access to COVID-19 Vaccines 15/04/2021 Editorial team In a vital step forward that will help accelerate global access to COVID-19 vaccines, Gavi, the vaccine alliance raised some $400 million in donations at a high-level event on Thursday, just a week after the global COVAX facility reached 100 countries with almost 40 million vaccine doses. The event was hosted by US Secretary of […] Continue reading -> ‘Unexamined Prejudices’: COVID-19 And Patents 15/04/2021 Sir Robin Jacob This past few weeks has seen a flurry of open letters from academics, politicians and NGOs dispatched to British Prime Minister Boris Johnson, US President Joe Biden and other heads of state, urging their governments to support a proposal to the World Trade Organization to for a proposed “waiver” suspending intellectual property (IP) rights, and […] Continue reading -> Gates Foundation: Technology Transfer, Not Patents Is Main Roadblock To Expanding Vaccine Production 14/04/2021 Svĕt Lustig Vijay & Elaine Ruth Fletcher Patents are not the main roadblock to producing enough coronavirus vaccines for the world – rather the challenge is technology transfer with manufacturers, said a top official at the Bill and Melinda Gates Foundation (BMGF) on Wednesday. His comments joined those of pharma voices in what seems to be a growing counter-trend to that of […] Continue reading -> Posts navigation Older postsNewer posts
Sustainable COVAX Vaccine Funding & Voluntary Manufacturing Licenses are Better Solutions than IP Waiver, Says IFPMA Head 16/05/2021 Elaine Ruth Fletcher In preparation for the next pandemic, the COVAX global vaccine facility “needs a pot of money, where they can be early movers” in competing for, and securing, vaccine doses. That could help scenarios like the ones seen recently, in which rich countries cornered the market on the first available COVID-19 vaccines, leading to severe shortages […] Continue reading -> WTO’s DG Okonjo-Iweala Welcomes New US Support For Waiver On COVID Vaccine IP: ‘We Need To Respond Urgently’ 06/05/2021 Chandre Prince, Raisa Santos & Elaine Ruth Fletcher World Trade Organization’s (WTO) director general Ngozi Onkonjo-Iweala on Thursday hailed the United States government’s decision to support the suspension of intellectual property rules on COVID-19 vaccines – while also emphasising the urgency of even more immediate actions to increase vaccine supplies to lower-income countries. In a statement after a two-day closed-door WTO General […] Continue reading -> BREAKING – US Swings Weight Behind Global IP Waiver On COVID Vaccines; WTO Inches Towards ‘Text-Based’ Negotiations 05/05/2021 Elaine Ruth Fletcher The United States has swung its weight behind a hotly-debated proposal by India and South Africa to suspend intellectual property rights on COVID-19 vaccines for the duration of the pandemic. The dramatic turnabout in the US position, announced Wednesday evening by US Trade Representative Katherine Tai, signals a sea change in the balance of powers […] Continue reading -> WHO Inches Closer to Approval of Chinese Sinopharm and Sinovac Vaccines 03/05/2021 Svĕt Lustig Vijay The World Health Organization (WHO) appears to be inching towards the approval of the Chinese Sinopharm and Sinovac vaccines as it struggles to fill a looming vaccine vacuum left by India’s Serum Institute – which has halted exports as the country continues to reel from a tragic coronavirus outbreak. Meanwhile, the WHO declared the latest […] Continue reading -> New Wave Of Appeals For WTO Waiver On IP For COVID Treatments Ahead of TRIPS Council Meeting 27/04/2021 Elaine Ruth Fletcher Nearly 400 members of the European Parliament (MEPs) and of national parliaments from across the European Union issued a joint appeal Tuesday calling for the European Commission to drop its opposition to a proposed WTO waiver on IP related to COVID-19 health technologies for the duration of the pandemic, being co-sponsored by India and South […] Continue reading -> The ‘Patent Bargain’, Public Good & COVID19 26/04/2021 Priti Patniak/Geneva Health Files As the hotly contested proposal for an IP waiver on COVID-related health products comes up again for debate on Friday, 30 April at the World Trade Organization’s TRIPS Council, legal expert Hyo Yoon Kang looks at the foundations of IP law to challenge “TRIPS waiver” naysayers. Geneva Health Files [GHF]: You have argued that IP […] Continue reading -> Gavi Receives $400 Million in Donations at High-Level Event To Expand Global Access to COVID-19 Vaccines 15/04/2021 Editorial team In a vital step forward that will help accelerate global access to COVID-19 vaccines, Gavi, the vaccine alliance raised some $400 million in donations at a high-level event on Thursday, just a week after the global COVAX facility reached 100 countries with almost 40 million vaccine doses. The event was hosted by US Secretary of […] Continue reading -> ‘Unexamined Prejudices’: COVID-19 And Patents 15/04/2021 Sir Robin Jacob This past few weeks has seen a flurry of open letters from academics, politicians and NGOs dispatched to British Prime Minister Boris Johnson, US President Joe Biden and other heads of state, urging their governments to support a proposal to the World Trade Organization to for a proposed “waiver” suspending intellectual property (IP) rights, and […] Continue reading -> Gates Foundation: Technology Transfer, Not Patents Is Main Roadblock To Expanding Vaccine Production 14/04/2021 Svĕt Lustig Vijay & Elaine Ruth Fletcher Patents are not the main roadblock to producing enough coronavirus vaccines for the world – rather the challenge is technology transfer with manufacturers, said a top official at the Bill and Melinda Gates Foundation (BMGF) on Wednesday. His comments joined those of pharma voices in what seems to be a growing counter-trend to that of […] Continue reading -> Posts navigation Older postsNewer posts
WTO’s DG Okonjo-Iweala Welcomes New US Support For Waiver On COVID Vaccine IP: ‘We Need To Respond Urgently’ 06/05/2021 Chandre Prince, Raisa Santos & Elaine Ruth Fletcher World Trade Organization’s (WTO) director general Ngozi Onkonjo-Iweala on Thursday hailed the United States government’s decision to support the suspension of intellectual property rules on COVID-19 vaccines – while also emphasising the urgency of even more immediate actions to increase vaccine supplies to lower-income countries. In a statement after a two-day closed-door WTO General […] Continue reading -> BREAKING – US Swings Weight Behind Global IP Waiver On COVID Vaccines; WTO Inches Towards ‘Text-Based’ Negotiations 05/05/2021 Elaine Ruth Fletcher The United States has swung its weight behind a hotly-debated proposal by India and South Africa to suspend intellectual property rights on COVID-19 vaccines for the duration of the pandemic. The dramatic turnabout in the US position, announced Wednesday evening by US Trade Representative Katherine Tai, signals a sea change in the balance of powers […] Continue reading -> WHO Inches Closer to Approval of Chinese Sinopharm and Sinovac Vaccines 03/05/2021 Svĕt Lustig Vijay The World Health Organization (WHO) appears to be inching towards the approval of the Chinese Sinopharm and Sinovac vaccines as it struggles to fill a looming vaccine vacuum left by India’s Serum Institute – which has halted exports as the country continues to reel from a tragic coronavirus outbreak. Meanwhile, the WHO declared the latest […] Continue reading -> New Wave Of Appeals For WTO Waiver On IP For COVID Treatments Ahead of TRIPS Council Meeting 27/04/2021 Elaine Ruth Fletcher Nearly 400 members of the European Parliament (MEPs) and of national parliaments from across the European Union issued a joint appeal Tuesday calling for the European Commission to drop its opposition to a proposed WTO waiver on IP related to COVID-19 health technologies for the duration of the pandemic, being co-sponsored by India and South […] Continue reading -> The ‘Patent Bargain’, Public Good & COVID19 26/04/2021 Priti Patniak/Geneva Health Files As the hotly contested proposal for an IP waiver on COVID-related health products comes up again for debate on Friday, 30 April at the World Trade Organization’s TRIPS Council, legal expert Hyo Yoon Kang looks at the foundations of IP law to challenge “TRIPS waiver” naysayers. Geneva Health Files [GHF]: You have argued that IP […] Continue reading -> Gavi Receives $400 Million in Donations at High-Level Event To Expand Global Access to COVID-19 Vaccines 15/04/2021 Editorial team In a vital step forward that will help accelerate global access to COVID-19 vaccines, Gavi, the vaccine alliance raised some $400 million in donations at a high-level event on Thursday, just a week after the global COVAX facility reached 100 countries with almost 40 million vaccine doses. The event was hosted by US Secretary of […] Continue reading -> ‘Unexamined Prejudices’: COVID-19 And Patents 15/04/2021 Sir Robin Jacob This past few weeks has seen a flurry of open letters from academics, politicians and NGOs dispatched to British Prime Minister Boris Johnson, US President Joe Biden and other heads of state, urging their governments to support a proposal to the World Trade Organization to for a proposed “waiver” suspending intellectual property (IP) rights, and […] Continue reading -> Gates Foundation: Technology Transfer, Not Patents Is Main Roadblock To Expanding Vaccine Production 14/04/2021 Svĕt Lustig Vijay & Elaine Ruth Fletcher Patents are not the main roadblock to producing enough coronavirus vaccines for the world – rather the challenge is technology transfer with manufacturers, said a top official at the Bill and Melinda Gates Foundation (BMGF) on Wednesday. His comments joined those of pharma voices in what seems to be a growing counter-trend to that of […] Continue reading -> Posts navigation Older postsNewer posts
BREAKING – US Swings Weight Behind Global IP Waiver On COVID Vaccines; WTO Inches Towards ‘Text-Based’ Negotiations 05/05/2021 Elaine Ruth Fletcher The United States has swung its weight behind a hotly-debated proposal by India and South Africa to suspend intellectual property rights on COVID-19 vaccines for the duration of the pandemic. The dramatic turnabout in the US position, announced Wednesday evening by US Trade Representative Katherine Tai, signals a sea change in the balance of powers […] Continue reading -> WHO Inches Closer to Approval of Chinese Sinopharm and Sinovac Vaccines 03/05/2021 Svĕt Lustig Vijay The World Health Organization (WHO) appears to be inching towards the approval of the Chinese Sinopharm and Sinovac vaccines as it struggles to fill a looming vaccine vacuum left by India’s Serum Institute – which has halted exports as the country continues to reel from a tragic coronavirus outbreak. Meanwhile, the WHO declared the latest […] Continue reading -> New Wave Of Appeals For WTO Waiver On IP For COVID Treatments Ahead of TRIPS Council Meeting 27/04/2021 Elaine Ruth Fletcher Nearly 400 members of the European Parliament (MEPs) and of national parliaments from across the European Union issued a joint appeal Tuesday calling for the European Commission to drop its opposition to a proposed WTO waiver on IP related to COVID-19 health technologies for the duration of the pandemic, being co-sponsored by India and South […] Continue reading -> The ‘Patent Bargain’, Public Good & COVID19 26/04/2021 Priti Patniak/Geneva Health Files As the hotly contested proposal for an IP waiver on COVID-related health products comes up again for debate on Friday, 30 April at the World Trade Organization’s TRIPS Council, legal expert Hyo Yoon Kang looks at the foundations of IP law to challenge “TRIPS waiver” naysayers. Geneva Health Files [GHF]: You have argued that IP […] Continue reading -> Gavi Receives $400 Million in Donations at High-Level Event To Expand Global Access to COVID-19 Vaccines 15/04/2021 Editorial team In a vital step forward that will help accelerate global access to COVID-19 vaccines, Gavi, the vaccine alliance raised some $400 million in donations at a high-level event on Thursday, just a week after the global COVAX facility reached 100 countries with almost 40 million vaccine doses. The event was hosted by US Secretary of […] Continue reading -> ‘Unexamined Prejudices’: COVID-19 And Patents 15/04/2021 Sir Robin Jacob This past few weeks has seen a flurry of open letters from academics, politicians and NGOs dispatched to British Prime Minister Boris Johnson, US President Joe Biden and other heads of state, urging their governments to support a proposal to the World Trade Organization to for a proposed “waiver” suspending intellectual property (IP) rights, and […] Continue reading -> Gates Foundation: Technology Transfer, Not Patents Is Main Roadblock To Expanding Vaccine Production 14/04/2021 Svĕt Lustig Vijay & Elaine Ruth Fletcher Patents are not the main roadblock to producing enough coronavirus vaccines for the world – rather the challenge is technology transfer with manufacturers, said a top official at the Bill and Melinda Gates Foundation (BMGF) on Wednesday. His comments joined those of pharma voices in what seems to be a growing counter-trend to that of […] Continue reading -> Posts navigation Older postsNewer posts
WHO Inches Closer to Approval of Chinese Sinopharm and Sinovac Vaccines 03/05/2021 Svĕt Lustig Vijay The World Health Organization (WHO) appears to be inching towards the approval of the Chinese Sinopharm and Sinovac vaccines as it struggles to fill a looming vaccine vacuum left by India’s Serum Institute – which has halted exports as the country continues to reel from a tragic coronavirus outbreak. Meanwhile, the WHO declared the latest […] Continue reading -> New Wave Of Appeals For WTO Waiver On IP For COVID Treatments Ahead of TRIPS Council Meeting 27/04/2021 Elaine Ruth Fletcher Nearly 400 members of the European Parliament (MEPs) and of national parliaments from across the European Union issued a joint appeal Tuesday calling for the European Commission to drop its opposition to a proposed WTO waiver on IP related to COVID-19 health technologies for the duration of the pandemic, being co-sponsored by India and South […] Continue reading -> The ‘Patent Bargain’, Public Good & COVID19 26/04/2021 Priti Patniak/Geneva Health Files As the hotly contested proposal for an IP waiver on COVID-related health products comes up again for debate on Friday, 30 April at the World Trade Organization’s TRIPS Council, legal expert Hyo Yoon Kang looks at the foundations of IP law to challenge “TRIPS waiver” naysayers. Geneva Health Files [GHF]: You have argued that IP […] Continue reading -> Gavi Receives $400 Million in Donations at High-Level Event To Expand Global Access to COVID-19 Vaccines 15/04/2021 Editorial team In a vital step forward that will help accelerate global access to COVID-19 vaccines, Gavi, the vaccine alliance raised some $400 million in donations at a high-level event on Thursday, just a week after the global COVAX facility reached 100 countries with almost 40 million vaccine doses. The event was hosted by US Secretary of […] Continue reading -> ‘Unexamined Prejudices’: COVID-19 And Patents 15/04/2021 Sir Robin Jacob This past few weeks has seen a flurry of open letters from academics, politicians and NGOs dispatched to British Prime Minister Boris Johnson, US President Joe Biden and other heads of state, urging their governments to support a proposal to the World Trade Organization to for a proposed “waiver” suspending intellectual property (IP) rights, and […] Continue reading -> Gates Foundation: Technology Transfer, Not Patents Is Main Roadblock To Expanding Vaccine Production 14/04/2021 Svĕt Lustig Vijay & Elaine Ruth Fletcher Patents are not the main roadblock to producing enough coronavirus vaccines for the world – rather the challenge is technology transfer with manufacturers, said a top official at the Bill and Melinda Gates Foundation (BMGF) on Wednesday. His comments joined those of pharma voices in what seems to be a growing counter-trend to that of […] Continue reading -> Posts navigation Older postsNewer posts
New Wave Of Appeals For WTO Waiver On IP For COVID Treatments Ahead of TRIPS Council Meeting 27/04/2021 Elaine Ruth Fletcher Nearly 400 members of the European Parliament (MEPs) and of national parliaments from across the European Union issued a joint appeal Tuesday calling for the European Commission to drop its opposition to a proposed WTO waiver on IP related to COVID-19 health technologies for the duration of the pandemic, being co-sponsored by India and South […] Continue reading -> The ‘Patent Bargain’, Public Good & COVID19 26/04/2021 Priti Patniak/Geneva Health Files As the hotly contested proposal for an IP waiver on COVID-related health products comes up again for debate on Friday, 30 April at the World Trade Organization’s TRIPS Council, legal expert Hyo Yoon Kang looks at the foundations of IP law to challenge “TRIPS waiver” naysayers. Geneva Health Files [GHF]: You have argued that IP […] Continue reading -> Gavi Receives $400 Million in Donations at High-Level Event To Expand Global Access to COVID-19 Vaccines 15/04/2021 Editorial team In a vital step forward that will help accelerate global access to COVID-19 vaccines, Gavi, the vaccine alliance raised some $400 million in donations at a high-level event on Thursday, just a week after the global COVAX facility reached 100 countries with almost 40 million vaccine doses. The event was hosted by US Secretary of […] Continue reading -> ‘Unexamined Prejudices’: COVID-19 And Patents 15/04/2021 Sir Robin Jacob This past few weeks has seen a flurry of open letters from academics, politicians and NGOs dispatched to British Prime Minister Boris Johnson, US President Joe Biden and other heads of state, urging their governments to support a proposal to the World Trade Organization to for a proposed “waiver” suspending intellectual property (IP) rights, and […] Continue reading -> Gates Foundation: Technology Transfer, Not Patents Is Main Roadblock To Expanding Vaccine Production 14/04/2021 Svĕt Lustig Vijay & Elaine Ruth Fletcher Patents are not the main roadblock to producing enough coronavirus vaccines for the world – rather the challenge is technology transfer with manufacturers, said a top official at the Bill and Melinda Gates Foundation (BMGF) on Wednesday. His comments joined those of pharma voices in what seems to be a growing counter-trend to that of […] Continue reading -> Posts navigation Older postsNewer posts
The ‘Patent Bargain’, Public Good & COVID19 26/04/2021 Priti Patniak/Geneva Health Files As the hotly contested proposal for an IP waiver on COVID-related health products comes up again for debate on Friday, 30 April at the World Trade Organization’s TRIPS Council, legal expert Hyo Yoon Kang looks at the foundations of IP law to challenge “TRIPS waiver” naysayers. Geneva Health Files [GHF]: You have argued that IP […] Continue reading -> Gavi Receives $400 Million in Donations at High-Level Event To Expand Global Access to COVID-19 Vaccines 15/04/2021 Editorial team In a vital step forward that will help accelerate global access to COVID-19 vaccines, Gavi, the vaccine alliance raised some $400 million in donations at a high-level event on Thursday, just a week after the global COVAX facility reached 100 countries with almost 40 million vaccine doses. The event was hosted by US Secretary of […] Continue reading -> ‘Unexamined Prejudices’: COVID-19 And Patents 15/04/2021 Sir Robin Jacob This past few weeks has seen a flurry of open letters from academics, politicians and NGOs dispatched to British Prime Minister Boris Johnson, US President Joe Biden and other heads of state, urging their governments to support a proposal to the World Trade Organization to for a proposed “waiver” suspending intellectual property (IP) rights, and […] Continue reading -> Gates Foundation: Technology Transfer, Not Patents Is Main Roadblock To Expanding Vaccine Production 14/04/2021 Svĕt Lustig Vijay & Elaine Ruth Fletcher Patents are not the main roadblock to producing enough coronavirus vaccines for the world – rather the challenge is technology transfer with manufacturers, said a top official at the Bill and Melinda Gates Foundation (BMGF) on Wednesday. His comments joined those of pharma voices in what seems to be a growing counter-trend to that of […] Continue reading -> Posts navigation Older postsNewer posts
Gavi Receives $400 Million in Donations at High-Level Event To Expand Global Access to COVID-19 Vaccines 15/04/2021 Editorial team In a vital step forward that will help accelerate global access to COVID-19 vaccines, Gavi, the vaccine alliance raised some $400 million in donations at a high-level event on Thursday, just a week after the global COVAX facility reached 100 countries with almost 40 million vaccine doses. The event was hosted by US Secretary of […] Continue reading -> ‘Unexamined Prejudices’: COVID-19 And Patents 15/04/2021 Sir Robin Jacob This past few weeks has seen a flurry of open letters from academics, politicians and NGOs dispatched to British Prime Minister Boris Johnson, US President Joe Biden and other heads of state, urging their governments to support a proposal to the World Trade Organization to for a proposed “waiver” suspending intellectual property (IP) rights, and […] Continue reading -> Gates Foundation: Technology Transfer, Not Patents Is Main Roadblock To Expanding Vaccine Production 14/04/2021 Svĕt Lustig Vijay & Elaine Ruth Fletcher Patents are not the main roadblock to producing enough coronavirus vaccines for the world – rather the challenge is technology transfer with manufacturers, said a top official at the Bill and Melinda Gates Foundation (BMGF) on Wednesday. His comments joined those of pharma voices in what seems to be a growing counter-trend to that of […] Continue reading -> Posts navigation Older postsNewer posts
‘Unexamined Prejudices’: COVID-19 And Patents 15/04/2021 Sir Robin Jacob This past few weeks has seen a flurry of open letters from academics, politicians and NGOs dispatched to British Prime Minister Boris Johnson, US President Joe Biden and other heads of state, urging their governments to support a proposal to the World Trade Organization to for a proposed “waiver” suspending intellectual property (IP) rights, and […] Continue reading -> Gates Foundation: Technology Transfer, Not Patents Is Main Roadblock To Expanding Vaccine Production 14/04/2021 Svĕt Lustig Vijay & Elaine Ruth Fletcher Patents are not the main roadblock to producing enough coronavirus vaccines for the world – rather the challenge is technology transfer with manufacturers, said a top official at the Bill and Melinda Gates Foundation (BMGF) on Wednesday. His comments joined those of pharma voices in what seems to be a growing counter-trend to that of […] Continue reading -> Posts navigation Older postsNewer posts
Gates Foundation: Technology Transfer, Not Patents Is Main Roadblock To Expanding Vaccine Production 14/04/2021 Svĕt Lustig Vijay & Elaine Ruth Fletcher Patents are not the main roadblock to producing enough coronavirus vaccines for the world – rather the challenge is technology transfer with manufacturers, said a top official at the Bill and Melinda Gates Foundation (BMGF) on Wednesday. His comments joined those of pharma voices in what seems to be a growing counter-trend to that of […] Continue reading -> Posts navigation Older postsNewer posts